Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. DELL
2. MDT
3. SPY
4. PANW
5. AAPL
6. SPGI
7. USO
8. GTLB
9. ENOV
10. MDB

Go back to Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies
(NASDAQ: KTTA) Delayed: 0.56 --0 (-0%)
Previous Close $0.56    52 Week High $ 
Open $0.56    52 Week Low $ 
Day High $0.56    P/E N/A 
Day Low $0.56    EPS $ 
Volume 50